Imugene launches first Aussie lymphoma cancer trial

In an Australian first, clinical cancer researcher and developer Imugene will launch its “azer-cel” trial against a difficult-to-treat form of non-Hodgkins lymphoma at Sydney’s Royal Prince Alfred Hospital.